- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Biosimilars/follow-on-biologics market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Biosimilars/follow-on-biologics market. Detailed analysis of key players, along with key growth strategies adopted by Biosimilars/follow-on-biologics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Biogen idec
Celltrion Biocon
Novartis (Sandoz)
Synthon Pharmaceuticals
Merck Serono (Merck)
Teva Pharmaceutical Industries
LG Life Sciences
Genentech (Roche)
Hospira
By Type:
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
By End-User:
Blood disorders
Oncology diseases
Chronic and autoimmune diseases
Growth hormone deficiencies
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Biosimilars/follow-on-biologics Market
-
1.3 Market Segment by Type
-
1.3.1 China Biosimilars/follow-on-biologics Market Size and Growth Rate of Human growth hormone from 2016 to 2027
-
1.3.2 China Biosimilars/follow-on-biologics Market Size and Growth Rate of Erythropoietin from 2016 to 2027
-
1.3.3 China Biosimilars/follow-on-biologics Market Size and Growth Rate of Monoclonal antibodies from 2016 to 2027
-
1.3.4 China Biosimilars/follow-on-biologics Market Size and Growth Rate of Insulin from 2016 to 2027
-
1.3.5 China Biosimilars/follow-on-biologics Market Size and Growth Rate of Interferon from 2016 to 2027
-
1.3.6 China Biosimilars/follow-on-biologics Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor from 2016 to 2027
-
1.3.7 China Biosimilars/follow-on-biologics Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Biosimilars/follow-on-biologics Market Size and Growth Rate of Blood disorders from 2016 to 2027
-
1.4.2 China Biosimilars/follow-on-biologics Market Size and Growth Rate of Oncology diseases from 2016 to 2027
-
1.4.3 China Biosimilars/follow-on-biologics Market Size and Growth Rate of Chronic and autoimmune diseases from 2016 to 2027
-
1.4.4 China Biosimilars/follow-on-biologics Market Size and Growth Rate of Growth hormone deficiencies from 2016 to 2027
-
1.4.5 China Biosimilars/follow-on-biologics Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Biosimilars/follow-on-biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Biosimilars/follow-on-biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Biosimilars/follow-on-biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Biosimilars/follow-on-biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Biosimilars/follow-on-biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Biosimilars/follow-on-biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Biosimilars/follow-on-biologics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Biosimilars/follow-on-biologics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Biosimilars/follow-on-biologics by Major Types
-
3.4.1 Market Size and Growth Rate of Human growth hormone
-
3.4.2 Market Size and Growth Rate of Erythropoietin
-
3.4.3 Market Size and Growth Rate of Monoclonal antibodies
-
3.4.4 Market Size and Growth Rate of Insulin
-
3.4.5 Market Size and Growth Rate of Interferon
-
3.4.6 Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor
-
3.4.7 Market Size and Growth Rate of Others
4 Segmentation of Biosimilars/follow-on-biologics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Biosimilars/follow-on-biologics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Biosimilars/follow-on-biologics in Blood disorders
-
4.4.2 Market Size and Growth Rate of Biosimilars/follow-on-biologics in Oncology diseases
-
4.4.3 Market Size and Growth Rate of Biosimilars/follow-on-biologics in Chronic and autoimmune diseases
-
4.4.4 Market Size and Growth Rate of Biosimilars/follow-on-biologics in Growth hormone deficiencies
-
4.4.5 Market Size and Growth Rate of Biosimilars/follow-on-biologics in Others
5 Market Analysis by Regions
-
5.1 China Biosimilars/follow-on-biologics Production Analysis by Regions
-
5.2 China Biosimilars/follow-on-biologics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Biosimilars/follow-on-biologics Landscape Analysis
-
6.1 North China Biosimilars/follow-on-biologics Landscape Analysis by Major Types
-
6.2 North China Biosimilars/follow-on-biologics Landscape Analysis by Major End-Users
7 Central China Biosimilars/follow-on-biologics Landscape Analysis
-
7.1 Central China Biosimilars/follow-on-biologics Landscape Analysis by Major Types
-
7.2 Central China Biosimilars/follow-on-biologics Landscape Analysis by Major End-Users
8 South China Biosimilars/follow-on-biologics Landscape Analysis
-
8.1 South China Biosimilars/follow-on-biologics Landscape Analysis by Major Types
-
8.2 South China Biosimilars/follow-on-biologics Landscape Analysis by Major End-Users
9 East China Biosimilars/follow-on-biologics Landscape Analysis
-
9.1 East China Biosimilars/follow-on-biologics Landscape Analysis by Major Types
-
9.2 East China Biosimilars/follow-on-biologics Landscape Analysis by Major End-Users
10 Northeast China Biosimilars/follow-on-biologics Landscape Analysis
-
10.1 Northeast China Biosimilars/follow-on-biologics Landscape Analysis by Major Types
-
10.2 Northeast China Biosimilars/follow-on-biologics Landscape Analysis by Major End-Users
11 Southwest China Biosimilars/follow-on-biologics Landscape Analysis
-
11.1 Southwest China Biosimilars/follow-on-biologics Landscape Analysis by Major Types
-
11.2 Southwest China Biosimilars/follow-on-biologics Landscape Analysis by Major End-Users
12 Northwest China Biosimilars/follow-on-biologics Landscape Analysis
-
12.1 Northwest China Biosimilars/follow-on-biologics Landscape Analysis by Major Types
-
12.2 Northwest China Biosimilars/follow-on-biologics Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Biogen idec
-
13.1.1 Biogen idec Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Celltrion Biocon
-
13.2.1 Celltrion Biocon Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Novartis (Sandoz)
-
13.3.1 Novartis (Sandoz) Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Synthon Pharmaceuticals
-
13.4.1 Synthon Pharmaceuticals Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Merck Serono (Merck)
-
13.5.1 Merck Serono (Merck) Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Teva Pharmaceutical Industries
-
13.6.1 Teva Pharmaceutical Industries Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 LG Life Sciences
-
13.7.1 LG Life Sciences Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Genentech (Roche)
-
13.8.1 Genentech (Roche) Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Hospira
-
13.9.1 Hospira Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Biosimilars/follow-on-biologics Market Size and Growth Rate of Human growth hormone from 2016 to 2027
-
Figure China Biosimilars/follow-on-biologics Market Size and Growth Rate of Erythropoietin from 2016 to 2027
-
Figure China Biosimilars/follow-on-biologics Market Size and Growth Rate of Monoclonal antibodies from 2016 to 2027
-
Figure China Biosimilars/follow-on-biologics Market Size and Growth Rate of Insulin from 2016 to 2027
-
Figure China Biosimilars/follow-on-biologics Market Size and Growth Rate of Interferon from 2016 to 2027
-
Figure China Biosimilars/follow-on-biologics Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor from 2016 to 2027
-
Figure China Biosimilars/follow-on-biologics Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Biosimilars/follow-on-biologics Market Size and Growth Rate of Blood disorders from 2016 to 2027
-
Figure China Biosimilars/follow-on-biologics Market Size and Growth Rate of Oncology diseases from 2016 to 2027
-
Figure China Biosimilars/follow-on-biologics Market Size and Growth Rate of Chronic and autoimmune diseases from 2016 to 2027
-
Figure China Biosimilars/follow-on-biologics Market Size and Growth Rate of Growth hormone deficiencies from 2016 to 2027
-
Figure China Biosimilars/follow-on-biologics Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Biosimilars/follow-on-biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Biosimilars/follow-on-biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Biosimilars/follow-on-biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Biosimilars/follow-on-biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Biosimilars/follow-on-biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Biosimilars/follow-on-biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Biosimilars/follow-on-biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Biosimilars/follow-on-biologics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Biosimilars/follow-on-biologics
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Biosimilars/follow-on-biologics by Different Types from 2016 to 2027
-
Table Consumption Share of Biosimilars/follow-on-biologics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Human growth hormone
-
Figure Market Size and Growth Rate of Erythropoietin
-
Figure Market Size and Growth Rate of Monoclonal antibodies
-
Figure Market Size and Growth Rate of Insulin
-
Figure Market Size and Growth Rate of Interferon
-
Figure Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Biosimilars/follow-on-biologics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Biosimilars/follow-on-biologics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Blood disorders
-
Figure Market Size and Growth Rate of Oncology diseases
-
Figure Market Size and Growth Rate of Chronic and autoimmune diseases
-
Figure Market Size and Growth Rate of Growth hormone deficiencies
-
Figure Market Size and Growth Rate of Others
-
Table China Biosimilars/follow-on-biologics Production by Regions
-
Table China Biosimilars/follow-on-biologics Production Share by Regions
-
Figure China Biosimilars/follow-on-biologics Production Share by Regions in 2016
-
Figure China Biosimilars/follow-on-biologics Production Share by Regions in 2021
-
Figure China Biosimilars/follow-on-biologics Production Share by Regions in 2027
-
Table China Biosimilars/follow-on-biologics Consumption by Regions
-
Table China Biosimilars/follow-on-biologics Consumption Share by Regions
-
Figure China Biosimilars/follow-on-biologics Consumption Share by Regions in 2016
-
Figure China Biosimilars/follow-on-biologics Consumption Share by Regions in 2021
-
Figure China Biosimilars/follow-on-biologics Consumption Share by Regions in 2027
-
Table North China Biosimilars/follow-on-biologics Consumption by Types from 2016 to 2027
-
Table North China Biosimilars/follow-on-biologics Consumption Share by Types from 2016 to 2027
-
Figure North China Biosimilars/follow-on-biologics Consumption Share by Types in 2016
-
Figure North China Biosimilars/follow-on-biologics Consumption Share by Types in 2021
-
Figure North China Biosimilars/follow-on-biologics Consumption Share by Types in 2027
-
Table North China Biosimilars/follow-on-biologics Consumption by End-Users from 2016 to 2027
-
Table North China Biosimilars/follow-on-biologics Consumption Share by End-Users from 2016 to 2027
-
Figure North China Biosimilars/follow-on-biologics Consumption Share by End-Users in 2016
-
Figure North China Biosimilars/follow-on-biologics Consumption Share by End-Users in 2021
-
Figure North China Biosimilars/follow-on-biologics Consumption Share by End-Users in 2027
-
Table Central China Biosimilars/follow-on-biologics Consumption by Types from 2016 to 2027
-
Table Central China Biosimilars/follow-on-biologics Consumption Share by Types from 2016 to 2027
-
Figure Central China Biosimilars/follow-on-biologics Consumption Share by Types in 2016
-
Figure Central China Biosimilars/follow-on-biologics Consumption Share by Types in 2021
-
Figure Central China Biosimilars/follow-on-biologics Consumption Share by Types in 2027
-
Table Central China Biosimilars/follow-on-biologics Consumption by End-Users from 2016 to 2027
-
Table Central China Biosimilars/follow-on-biologics Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Biosimilars/follow-on-biologics Consumption Share by End-Users in 2016
-
Figure Central China Biosimilars/follow-on-biologics Consumption Share by End-Users in 2021
-
Figure Central China Biosimilars/follow-on-biologics Consumption Share by End-Users in 2027
-
Table South China Biosimilars/follow-on-biologics Consumption by Types from 2016 to 2027
-
Table South China Biosimilars/follow-on-biologics Consumption Share by Types from 2016 to 2027
-
Figure South China Biosimilars/follow-on-biologics Consumption Share by Types in 2016
-
Figure South China Biosimilars/follow-on-biologics Consumption Share by Types in 2021
-
Figure South China Biosimilars/follow-on-biologics Consumption Share by Types in 2027
-
Table South China Biosimilars/follow-on-biologics Consumption by End-Users from 2016 to 2027
-
Table South China Biosimilars/follow-on-biologics Consumption Share by End-Users from 2016 to 2027
-
Figure South China Biosimilars/follow-on-biologics Consumption Share by End-Users in 2016
-
Figure South China Biosimilars/follow-on-biologics Consumption Share by End-Users in 2021
-
Figure South China Biosimilars/follow-on-biologics Consumption Share by End-Users in 2027
-
Table East China Biosimilars/follow-on-biologics Consumption by Types from 2016 to 2027
-
Table East China Biosimilars/follow-on-biologics Consumption Share by Types from 2016 to 2027
-
Figure East China Biosimilars/follow-on-biologics Consumption Share by Types in 2016
-
Figure East China Biosimilars/follow-on-biologics Consumption Share by Types in 2021
-
Figure East China Biosimilars/follow-on-biologics Consumption Share by Types in 2027
-
Table East China Biosimilars/follow-on-biologics Consumption by End-Users from 2016 to 2027
-
Table East China Biosimilars/follow-on-biologics Consumption Share by End-Users from 2016 to 2027
-
Figure East China Biosimilars/follow-on-biologics Consumption Share by End-Users in 2016
-
Figure East China Biosimilars/follow-on-biologics Consumption Share by End-Users in 2021
-
Figure East China Biosimilars/follow-on-biologics Consumption Share by End-Users in 2027
-
Table Northeast China Biosimilars/follow-on-biologics Consumption by Types from 2016 to 2027
-
Table Northeast China Biosimilars/follow-on-biologics Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Biosimilars/follow-on-biologics Consumption Share by Types in 2016
-
Figure Northeast China Biosimilars/follow-on-biologics Consumption Share by Types in 2021
-
Figure Northeast China Biosimilars/follow-on-biologics Consumption Share by Types in 2027
-
Table Northeast China Biosimilars/follow-on-biologics Consumption by End-Users from 2016 to 2027
-
Table Northeast China Biosimilars/follow-on-biologics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Biosimilars/follow-on-biologics Consumption Share by End-Users in 2016
-
Figure Northeast China Biosimilars/follow-on-biologics Consumption Share by End-Users in 2021
-
Figure Northeast China Biosimilars/follow-on-biologics Consumption Share by End-Users in 2027
-
Table Southwest China Biosimilars/follow-on-biologics Consumption by Types from 2016 to 2027
-
Table Southwest China Biosimilars/follow-on-biologics Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Biosimilars/follow-on-biologics Consumption Share by Types in 2016
-
Figure Southwest China Biosimilars/follow-on-biologics Consumption Share by Types in 2021
-
Figure Southwest China Biosimilars/follow-on-biologics Consumption Share by Types in 2027
-
Table Southwest China Biosimilars/follow-on-biologics Consumption by End-Users from 2016 to 2027
-
Table Southwest China Biosimilars/follow-on-biologics Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Biosimilars/follow-on-biologics Consumption Share by End-Users in 2016
-
Figure Southwest China Biosimilars/follow-on-biologics Consumption Share by End-Users in 2021
-
Figure Southwest China Biosimilars/follow-on-biologics Consumption Share by End-Users in 2027
-
Table Northwest China Biosimilars/follow-on-biologics Consumption by Types from 2016 to 2027
-
Table Northwest China Biosimilars/follow-on-biologics Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Biosimilars/follow-on-biologics Consumption Share by Types in 2016
-
Figure Northwest China Biosimilars/follow-on-biologics Consumption Share by Types in 2021
-
Figure Northwest China Biosimilars/follow-on-biologics Consumption Share by Types in 2027
-
Table Northwest China Biosimilars/follow-on-biologics Consumption by End-Users from 2016 to 2027
-
Table Northwest China Biosimilars/follow-on-biologics Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Biosimilars/follow-on-biologics Consumption Share by End-Users in 2016
-
Figure Northwest China Biosimilars/follow-on-biologics Consumption Share by End-Users in 2021
-
Figure Northwest China Biosimilars/follow-on-biologics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Biogen idec
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen idec
-
Figure Sales and Growth Rate Analysis of Biogen idec
-
Figure Revenue and Market Share Analysis of Biogen idec
-
Table Product and Service Introduction of Biogen idec
-
Table Company Profile and Development Status of Celltrion Biocon
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion Biocon
-
Figure Sales and Growth Rate Analysis of Celltrion Biocon
-
Figure Revenue and Market Share Analysis of Celltrion Biocon
-
Table Product and Service Introduction of Celltrion Biocon
-
Table Company Profile and Development Status of Novartis (Sandoz)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis (Sandoz)
-
Figure Sales and Growth Rate Analysis of Novartis (Sandoz)
-
Figure Revenue and Market Share Analysis of Novartis (Sandoz)
-
Table Product and Service Introduction of Novartis (Sandoz)
-
Table Company Profile and Development Status of Synthon Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synthon Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Synthon Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Synthon Pharmaceuticals
-
Table Product and Service Introduction of Synthon Pharmaceuticals
-
Table Company Profile and Development Status of Merck Serono (Merck)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck Serono (Merck)
-
Figure Sales and Growth Rate Analysis of Merck Serono (Merck)
-
Figure Revenue and Market Share Analysis of Merck Serono (Merck)
-
Table Product and Service Introduction of Merck Serono (Merck)
-
Table Company Profile and Development Status of Teva Pharmaceutical Industries
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries
-
Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries
-
Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries
-
Table Product and Service Introduction of Teva Pharmaceutical Industries
-
Table Company Profile and Development Status of LG Life Sciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of LG Life Sciences
-
Figure Sales and Growth Rate Analysis of LG Life Sciences
-
Figure Revenue and Market Share Analysis of LG Life Sciences
-
Table Product and Service Introduction of LG Life Sciences
-
Table Company Profile and Development Status of Genentech (Roche)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech (Roche)
-
Figure Sales and Growth Rate Analysis of Genentech (Roche)
-
Figure Revenue and Market Share Analysis of Genentech (Roche)
-
Table Product and Service Introduction of Genentech (Roche)
-
Table Company Profile and Development Status of Hospira
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira
-
Figure Sales and Growth Rate Analysis of Hospira
-
Figure Revenue and Market Share Analysis of Hospira
-
Table Product and Service Introduction of Hospira
-